⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IOVA News
Iovance Biotherapeutics, Inc. Common Stock
Form 8-K
sec.gov
IOVA
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
globenewswire.com
IOVA
GTBP
NKTX
IBRX
FATE
Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
globenewswire.com
IOVA
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
globenewswire.com
HIVE
IOVA
SGMO
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
globenewswire.com
IOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
IOVA
Iovance Biotherapeutics to Present at Upcoming Conference
globenewswire.com
IOVA
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight
globenewswire.com
AZN
PBYI
IOVA
REGN
BMY
MRK
AMGN
BDX
QGEN
ABT
DHR
BIO
TMO
FMS
DXC
NVDA
IBM
GEHC
AI
Form 8-K
sec.gov
IOVA
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
globenewswire.com
IOVA